"The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape B"...
- Patient Information:
Details with Side Effects
Side effects associated with Brevital Sodium (methohexital sodium for injection) are extensions of pharmacologic effects and include:
Drug Abuse And Dependence
Controlled Substance-Brevital Sodium (methohexital sodium for injection) is a Schedule IV drug.
Brevital Sodium (methohexital sodium for injection) may be habit-forming.
Read the Brevital Sodium (methohexital sodium for injection) Side Effects Center for a complete guide to possible side effects
Prior chronic administration of barbiturates or phenytoin (e. g. for seizure disorder) appears to reduce the effectiveness of Brevital Sodium (methohexital sodium for injection) . Barbiturates may influence the metabolism of other concomitantly used drugs, such as phentyoin, halothane, anticoagulants, corticosteroids, ethyl alcohol, and propylene glycol-containing solutions.
Last reviewed on RxList: 6/14/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Brevital Sodium Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.